NRIX · Nurix Therapeutics, Inc. · Documents
$26.10
+1.17 (+4.69%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$2.72B
Shares
109.25M
Volume · Oct 20
3.98M
Avg daily vol (3M)
1.56M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-04-10 | — | |
| 8-K | — | 2024-04-09 | — | |
| DEF 14A | — | 2024-03-27 | 2024-05-20 | |
| 8-K | — | 2024-03-11 | — | |
| 10-K | — | 2024-02-15 | 2023-11-30 | |
| 8-K | — | 2024-02-15 | — | |
| 8-K | — | 2024-01-08 | — | |
| 8-K | — | 2023-12-11 | — | |
| 8-K | — | 2023-11-13 | — | |
| 8-K | — | 2023-11-01 | — | |
| 10-Q | — | 2023-10-12 | 2023-08-31 | |
| 8-K | — | 2023-10-12 | — | |
| 8-K | — | 2023-09-07 | 2023-09-06 | |
| 8-K | — | 2023-07-13 | — | |
| 10-Q | — | 2023-07-13 | 2023-05-31 | |
| 8-K | — | 2023-05-04 | — | |
| 10-Q | — | 2023-04-13 | 2023-02-28 | |
| 8-K | — | 2023-04-13 | — | |
| 8-K | — | 2023-04-10 | 2023-04-05 | |
| DEF 14A | — | 2023-03-24 | 2023-05-04 | |
| 8-K | — | 2023-03-13 | — | |
| 8-K | — | 2023-02-09 | — | |
| 10-K | — | 2023-02-09 | 2022-11-30 | |
| 8-K | — | 2023-01-09 | — | |
| 8-K | — | 2022-12-16 | 2022-12-15 | |
| 8-K | — | 2022-12-13 | 2022-12-12 | |
| 8-K | — | 2022-10-26 | — | |
| 10-Q | — | 2022-10-06 | 2022-08-31 | |
| 8-K | — | 2022-10-06 | — | |
| 8-K | — | 2022-09-14 | 2022-09-12 | |
| 8-K | — | 2022-07-08 | 2022-07-07 | |
| 8-K | — | 2022-07-07 | — | |
| 10-Q | — | 2022-07-07 | 2022-05-31 | |
| 8-K | — | 2022-05-26 | — | |
| 8-K | — | 2022-05-16 | 2022-05-15 | |
| 8-K | — | 2022-05-06 | 2022-05-05 | |
| 10-Q | — | 2022-04-08 | 2022-02-28 | |
| 8-K | — | 2022-04-07 | — | |
| DEF 14A | — | 2022-03-25 | 2022-05-05 | |
| 8-K | — | 2022-03-07 | 2022-03-02 | |
| 8-K | — | 2022-03-02 | 2022-03-01 | |
| 10-K | — | 2022-01-28 | 2021-11-30 | |
| 8-K | — | 2022-01-27 | — | |
| 8-K | — | 2022-01-10 | — | |
| 8-K | — | 2021-10-27 | — | |
| 10-Q | — | 2021-10-14 | 2021-08-31 | |
| 8-K | — | 2021-10-14 | — | |
| 8-K | — | 2021-09-30 | 2021-09-25 | |
| 8-K | — | 2021-07-13 | — | |
| 10-Q | — | 2021-07-13 | 2021-05-31 |
Showing 51–100 of 115 filings
Key facts
CIK
1549595
CUSIP
67080M103
13F (30d)
12 filings
12 filers
Visit website
Investor relations